Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-13-002337
Filing Date
2013-12-27
Accepted
2013-12-27 19:59:37
Documents
1
Period of Report
2013-08-15

Document Format Files

Seq Description Document Type Size
1 e611697_4-aselage.html 4  
1 e611697_4-aselage.xml 4 7892
  Complete submission text file 0001193805-13-002337.txt   9279
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
ASELAGE STEVE (Reporting) CIK: 0001221599 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53293 | Film No.: 131301387

Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
SIC: 2834 Pharmaceutical Preparations